Oncology has developed into the biggest therapy class in terms of revenues for the pharmaceutical industry.1 A better understanding of cancer cell mechanisms, innovative biologic drugs
Community News
Trends and Opportunities in Antibiotic Development for Multidrug-Resistant Bacterial Infections
July 12, 2018
The advent of antibiotic therapy was one of the most impactful medical innovations of the 20th century. However, as resistance has waxed and antibiotic development has waned, multidrug-resistant bacterial
DNA Barcoding for Drug Discovery
July 12, 2018
DNA encoded chemical libraries (DECLs) is an emerging technology used for high-throughput screening (HTS). DECL technology is rapidly advancing, and a large market exists
Alzheimer’s Early Detection
July 12, 2018
While the AD biomarker diagnostic market currently faces many barriers to clinical adoption due to lack of insurance testing coverage and biomarkers based on anti-amyloid hypothesis
The Future of CRISPR Therapeutics for Human Hematopoietic Stem Cell Derived Diseases
July 12, 2018
Using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) to genetically engineer hematopoietic stem cells (HSCs) for therapeutic applications is an emerging market that holds promise